US scientist casts doubt on AstraZeneca&#39;s Crestor
113293
AstraZeneca was dealt a blow yesterday when an official from the US&#39;s drugs watchdog questioned whether one of its key products ought to be sold in the world&#39;s largest pharmaceuticals market.
433316
AstraZeneca Plc, the UK&#39;s second-biggest drugmaker, delayed the regulatory filing of its diabetes medicine Galida by a year to 2007, a setback that comes a month after US scientists questioned
256773
The US Food and Drug Administration said on Friday that Senate testimony by a veteran FDA researcher regarding safety risks for five drugs does not reflect the views of the agency.
243665
Stem cell researchers continue to question Advanced Cell Technology scientists on their increasingly contested paper published recently in Nature.. In Bodyhack.
479423
AstraZeneca Plc's cholesterol-lowering drug Crestor performed better than Pfizer Inc's Lipitor in an AstraZeneca-funded study of patients with metabolic syndrome, according to results released on Monday.
619694
ASTRAZENECAâS anti-clotting drug Exanta is unlikely to win US approval in the near future, the company said as it revealed a delay with another new drug, Galida for diabetes.
193540
The US Food and Drug Administration yesterday sought to distance itself from remarks by one of its top safety officials that raised concerns about key drugs made by Astrazeneca and Glaxo Smithkline.
75357
The recently marketed statin drug Crestor was more effective in treating high cholesterol than the competing medication Lipitor among patients with metabolic syndrome, according to a new study funded by Crestor&#39;s manufacturer.
568595
AstraZeneca Plc's cholesterol-lowering  drug Crestor has been linked to the death of a patient,  Europe's third largest drugmaker said on Monday.
371559
Drugs giant AstraZeneca today acknowledged that its anti-clotting drug Exanta is unlikely to win US approval any time soon and revealed a one-year delay with another new drug, Galida, for diabetes.
574773
A newspaper advertisement for AstraZeneca Plc's cholesterol drug Crestor that touts patient safety is misleading and should no longer be published, regulators warned in a letter released Wednesday.
101261
Following results of recent clinical trials on popular cholesterol drugs, cardiologists are questioning whether a patientâs cholesterol should be all that matters.
307878
It&#39;s made by Biogen Idec and Elan. It was orginally called, Antegren until the US Food and Drug Administration requested a name change, to avoid confusion with other drugs.
703493
By Danny Robbins, Fort Worth Star-Telegram, Texas  Sep. 10--Three Nobel Prize-winning scientists have complained to New York Attorney General Eliot Spitzer that Web sites are falsely tying their research to the dietary supplements of Mannatech Inc.
45431
An internal survey finds about two-thirds of FDA scientists lack confidence in the agency&#39;s monitoring of the safety of prescription drugs now on the market.
16283
Two-thirds of scientists working for the US medicines regulator have expressed a lack of confidence in the federal safety monitoring of prescription drugs, according to documents disclosed by two lobby groups.
2126
Shares of large US and European drug makers fell on Thursday after a prominent cardiologist questioned the safety of new arthritis drugs and the performance of US regulators in monitoring drug safety.